Subset of ALS patients find hope through newly approved medication

Subset of ALS patients find hope through newly approved medication

Roughly 3,000 to 4,000 Canadians are currently living with Amyotrophic lateral sclerosis (ALS), and for the majority of them, better therapies are too far off to make a difference in their conditions. After diagnosis, people with ALS tend to lose their lives to the progressive disease within two to five years.